Abstract:Background Porcine reproductive and respiratory syndrome virus (PRRSV) is the causative agent of porcine reproductive and respiratory syndrome; it is one of the most economically important viral diseases affecting the swine industry worldwide. At present, neither live-attenuated nor inactivated PRRSV vaccines can provide sustainable disease control. Our previous studies have demonstrated that PRRSV infection can produce the auto-anti-idiotypic antibodies (aAb2s) specific to the idiotypic antibodies against PRRSV GP5, which plays an important role in the host immune responses to PRRSV infection. In the present study, a single-chain variable antibody fragment (scFv) from the monoclonal anti-idiotypic antibody specific for the idiotypic antibody against GP5 was expressed in MARC-145 cells and its effect on virus infection in vitro was evaluated. Methods An scFv was constructed from the anti-idiotypic antibody (Mab2-5G2) and was named 5G2scFv. The lentiviral vector system was used as a vehicle to deliver 5G2scFv into MARC-145 cells. The effect of 5G2scFv expression in MARC-145 was analysed by determining the PRRSV N protein level and the virus titre in the supernatant. Virus attachment and the level of type I interferon (IFN) were determined to elucidate the mechanism of the scFv effect. Results 5G2scFv was delivered in MARC-145 cells using the lentiviral vector system as confirmed by the western blot and indirect immunofluorescence assays. The PRRSV challenge experiments demonstrated that expressed 5G2scFv in MARC-145 strongly reduced PRRSV infection and replication by inhibiting protein synthesis and progeny virus production. This effect was not due to the change of viability or virus binding, but increased IFN-α at messenger RNA and protein levels. Conclusions The expression of the anti-idiotypic antibody 5G2scFv in MARC-145 cells has the interferential effect on PRRSV infection in the cells by induction of IFN-α, which provides a novel therapeutic approach for PRRSV infection.

Single-chain Anti-Idiotypic Antibody Retains Its Specificity to Porcine Reproductive and Respiratory Syndrome Virus GP5.

Generation Of Internal Image Monoclonal Anti-Idiotypic Antibodies Against Idiotypic Antibodies To Gp5 Antigen Of Porcine Reproductive And Respiratory Syndrome Virus

Intracellular Expression of an Anti-Idiotypic Antibody Single-Chain Variable Fragment Reduces Porcine Reproductive and Respiratory Syndrome Virus Infection in MARC-145 Cells

Construction, Expression and Identification of Anti-Idiotype Scfv Specific to Anti-Prrsv GP5 Antibody

Development of a monoclonal antibody against PRRSV glycoprotein 3 using an immuodominant peptide as immunogen

Development and Biological Characterization of Monoclonal Antibody with Neutralization Activity Against GP5 Protein of Porcine Reproduction and Respiratory Syndrome Virus

Broad neutralization activity against both PRRSV-1 and PRRSV-2 and enhancement of cell mediated immunity against PRRSV by a novel IgM monoclonal antibody

Development and Identification of Monoclonal Antibodies Against Porcine Reproductive and Respiratory Syndrome Virus

Immunogenicity of the Glycoprotein 5 Truncated Trans-Membrane Regions of Porcine Reproductive and Respiratory Syndrome Virus

Development and Characterization of Monoclonal Antibody Against GP5 Protein of Porcine Reproduction and Respiratory Syndrome Virus

Development of monoclonal antibody for differentiating porcine reproductive and respiratory syndrome virus and identification of a novel non-structural protein 2 epitope peptide

Immune Response to Fc Tagged Gp5 Glycoproteins of Porcine Reproductive and Respiratory Syndrome Virus

Development of the Monoclonal Antibodies Against Porcine Reproductive and Respiratory Syndrome Virus(prrsv)

Preparation and Identification of Monoclonal Antibodies Against GP5 Protein PRRSV

Identification of a Linear B-cell Epitope on Glycoprotein (GP) 2a of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).

Porcine Reproductive and Respiratory Syndrome Virus Engineered by Serine Substitution on the 44th Amino Acid of GP5 Resulted in a Potential Vaccine Candidate with the Ability to Produce High Levels of Neutralizing Antibody

Identificationof a novel linear epitope on the porcine reproductive and respiratory syndrome virus nucleocapsid protein, as recognized by a specific monoclonal antibody

Identification and Characterization of Auto-Anti-Idiotypic Antibodies Specific for Antibodies Against Porcine Reproductive and Respiratory Syndrome Virus Envelope Glycoprotein (Gp5)

Expression of Truncated NSP2 Protein of Porcine Reproduction and Respiratory Syndrome Virus in E.coli and Preparation of Monoclonal Antibodies Against NSP2 Protein

Development of Monoclonal Antibodies Specifically Recognizing the Nonstructural Protein 12 of Type 2 Porcine Reproductive and Respiratory Syndrome Virus

Characterisation of novel linear antigen epitopes on North American-type porcine reproductive and respiratory syndrome virus M protein